Kurser indlæses...
Prognose
| Køb |
3 |
| Behold |
12 |
| Sælg |
2 |
Nyheder Til nyhedsfeedet
Genworth Financial: stock falls after CEO takes medical leave
Shares of Genworth Financial fell 1.9% in after-hours trading after CEO Tom McInerney is taking a temporary leave due to health issues. The board appointed Jerome Upton, the company's CFO, as interim president and CEO with immediate effect; Upton has worked at the company since 1998 and has been CFO since March 2023. The board said the management team is well positioned while Genworth continues to provide its services to support care decisions and long-term care planning. » Mere på de.investing.com
Genworth beats earnings expectations in Q1 thanks to strong Enact performance
Genworth reported adjusted operating earnings of $0.28 per share in the first quarter, well ahead of analysts’ expectations, driven by mortgage-insurance subsidiary Enact, which contributed $140 million to results and released reserves. Enact also raised its quarterly dividend and delivered solid PMIERs solvency of 162%. At the same time, the CareScout platform grew strongly (placements +158% year‑over‑year), and Genworth continued capital actions, including $66 million in buybacks and $99 million in capital returns from Enact, with management targeting an additional capital return of around $500 million for 2026. » Mere på de.investing.com
Genworth Financial posts $0.02 EPS and misses Q4 2025 by a wide margin
Genworth Financial reported Q4 2025 earnings of $0.02 per share versus $0.11 expected, missing estimates by a wide margin. The company recorded a net income of $2 million; the mortgage-insurance segment Enact contributed an adjusted $146 million, while the closed‑block book—particularly long‑term care—was weighed down by heavy losses. The stock rose 3.55% premarket despite the disappointment. Genworth plans investments in the CareScout platform and is targeting significant growth in its services business in 2026. » Mere på de.investing.com
Historisk udbytte Udbytte
Alle nøgletal for udbytte Alle nøgletalVirksomhedstal
| (EUR) | juni 2026 | YoY |
|---|---|---|
| Omsætning | 1,67 mia. | 13,68 % |
| Bruttofortjeneste | 1,67 mia. | 2.294,23 % |
| Nettoresultat | 41,18 mio. | 4,82 % |
| EBITDA | 165,6 mio. | 29,27 % |
Fundamentale data
| Nøgletal | Værdi |
|---|---|
Markedsværdi | 2,96 mia. € |
Antal aktier | 377,85 mio. |
Højeste/laveste i 52 uger | 9,53 € - 6,99 € |
| Udbytte | Nej |
Beta | 0,88 |
P/E (PE Ratio) | 16,11 |
PEG (PEG Ratio) | 0,81 |
K/I (PB Ratio) | 0,38 |
P/S (PS Ratio) | 0,47 |
Virksomhedsprofil
Genworth Financial, Inc. tilbyder forsikringsprodukter i USA og internationalt. Virksomheden opererer i tre segmenter: Enact, U.S. Life Insurance og Runoff. Enact-segmentet tilbyder boliglånsforsikringsprodukter, som primært dækker prime-baserede, individuelt underwritten boliglån; samt poolboliglånsforsikringsprodukter. U.S. Life Insurance-segmentet tilbyder langtidsplejeforsikringsprodukter og servicerer traditionelle livsforsikringer og faste livrenteprodukter i USA. Runoff-segmentet omfatter variable livrenter, variable livsforsikringer og virksomhedsejede livsforsikringer samt finansieringsaftaler. Virksomheden distribuerer sine produkter gennem salgsstyrke, interne salgsrepræsentanter og digitale markedsføringsprogrammer. Selskabet blev grundlagt i 1871 og har hovedkvarter i Richmond, Virginia.
| Navn | Genworth Financial 'A' |
| CEO | Tom McInerney |
| Hjemsted | Glen Allen,
va USA |
| Websted | |
| Sektor | Finans |
| Branche | Finansielle tjenester |
| Børsnotering | 25.05.2004 |
| Medarbejdere | 3.100 |
Tickersymboler
| Børs | Symbol |
|---|---|
NYSE | GNW |
Frankfurt | GGK.F |
Düsseldorf | GGK.DU |